Stay updated on EDP-938 in Hematopoietic Cell Transplant Recipients Clinical Trial
Sign up to get notified when there's something new on the EDP-938 in Hematopoietic Cell Transplant Recipients Clinical Trial page.

Latest updates to the EDP-938 in Hematopoietic Cell Transplant Recipients Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page has undergone significant content removal, particularly regarding the details of a Phase 2b study on EDP-938 for RSV infections, including inclusion and exclusion criteria. The revision number has also been updated from v2.14.4 to v2.15.0.SummaryDifference19%
- Check34 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check41 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check77 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check92 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to EDP-938 in Hematopoietic Cell Transplant Recipients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EDP-938 in Hematopoietic Cell Transplant Recipients Clinical Trial page.